project id: TCGA-ESCA; case submitter id: TCGA-R6-A6L4; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 7.5; age at index: 27; days to birth: -10222; days to death: 496; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1985; age at diagnosis: 10222; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 447.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; cigarettes per day: 0.6027397260273972; pack years smoked: 11.0; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 427; days to sample procurement: 0; initial weight: 1.0; sample id: b29b5b89-ef84-4532-9df0-f6bede55e01c; sample submitter id: TCGA-R6-A6L4-01A; portion id: 2c38cab9-97b5-4b91-8ba3-faf8322f42c8; portion submitter id: TCGA-R6-A6L4-01A-11; slide id: 67efb685-ec0c-4837-b866-2595df38ea29; slide submitter id: TCGA-R6-A6L4-01Z-00-DX1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 20.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;